Page de couverture de Research To Practice | Oncology Videos

Research To Practice | Oncology Videos

Research To Practice | Oncology Videos

Auteur(s): Dr Neil Love
Écouter gratuitement

À propos de cet audio

Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.Copyright © 2023 Research To Practice. All Rights Reserved. Hygiène et mode de vie sain Science Troubles et maladies
Épisodes
  • Extrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future Management
    Sep 21 2025

    Featuring an interview with Dr Jonathan Strosberg, including the following topics:

    • Overview of extrapulmonary neuroendocrine carcinoma (NEC) (0:00)
    • Treatment strategies for extrapulmonary NEC (10:26)
    • Targeting DLL3 in extrapulmonary NEC (18:49)
    • Early clinical data with obrixtamig for extrapulmonary NEC (21:56)
    • Additional investigational agents for extrapulmonary NEC (25:44)
    • Case: A woman in her mid 50s with poorly differentiated metastatic NEC of unknown primary (27:20)
    • Case: A man in his early 60s with poorly differentiated metastatic esophageal NEC (32:30)
    • Clinical management of well-differentiated NEC (36:58)

    CME information and select publications

    Voir plus Voir moins
    45 min
  • Oncology Nursing Update: Multiple Myeloma — An Interview with Dr Beth Faiman on CAR T-Cell Therapy
    Sep 20 2025

    Featuring an interview with Dr Beth Faiman, including the following topics:

    • Clinical practice background and historical view of treatment for multiple myeloma (MM) (0:00)
    • Fundamental principles associated with chimeric antigen receptor (CAR) T-cell therapy (7:19)
    • Sequencing of CAR T-cell therapy and bispecific antibodies in the MM treatment landscape (9:00)
    • Patient eligibility to receive CAR T-cell therapy (13:23)
    • Differentiating among approved CAR T-cell therapies for MM (18:18)
    • Durability of responses to CAR T-cell therapy for MM (24:01)
    • Neurotoxicity with CAR T-cell therapies for MM (26:26)
    • Minimal residual disease monitoring in MM (29:39)
    • Support systems for the management of toxicities associated with CAR T-cell therapy (35:10)
    • Patients with MM experiencing durable responses to CAR T-cell therapy (43:11)

    NCPD information and select publications

    Voir plus Voir moins
    53 min
  • Extrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future Management (Companion Faculty Lecture)
    Sep 19 2025

    Featuring a slide presentation and related discussion from Dr Jonathan Strosberg, including the following topics:

    • Overview of the classification, grading and incidence of neuroendocrine carcinoma (NEC) (0:00)
    • Overview of mutational profile, biomarker assessments and prognosis of NEC (3:45)
    • Current treatment paradigm for extrapulmonary NEC (8:59)
    • DLL3 as an emerging target biomarker in extrapulmonary NEC (17:46)
    • Novel therapeutic agents under investigation for extrapulmonary NEC (23:05)

    CME information and select publications

    Voir plus Voir moins
    26 min
Pas encore de commentaire